Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research is a clinical research site located in New York, New York, United States 10035.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Treatment-resistant Schizophrenia.
Sponsors: Newron Pharmaceuticals SPA.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research has 1 clinical trials on record, with 1 currently active. Their work covers Treatment-resistant Schizophrenia.
Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.